Advances in Clinical and Experimental Medicine
2020, vol. 29, nr 6, June, p. 707–713
Publication type: original article
Streptococcus agalactiae and Chlamydia trachomatis detection in women without symptoms of infection
1 Department of Basic Sciences, Faculty of Health Sciences, Wroclaw Medical University, Poland
2 Department of Gynaecology and Obstetrics, Faculty of Health Sciences, Wroclaw Medical University, Poland
3 Faculty of Medical Sciences, Public Higher Medical Professional School in Opole, Poland
Background. Chlamydia trachomatis (C. trachomatis) and Streptococcus agalactiae (GBS) may be present in the female cervical canal without any symptoms of infection. Chronic chlamydial infections lead to many serious complications and perinatal infections, while the presence of GBS is a reservoir for infections of newborns or invasive streptococcal infection in adults.
Objectives. To examine healthy women for C. trachomatis without symptoms from the reproductive system, assess the frequency of asymptomatic infections, detect GBS in the cervical canal, demonstrate differences in drug susceptibility, and determine the serotype of S. agalactiae strains and correlations among the ones present in the cervical canal.
Material and Methods. A total of 315 cervical swabs were collected for genetic and microbiological analysis for the presence of C. trachomatis and S. agalactiae. Latex and diffusion-disk methods were used to determine the serotype and susceptibility of streptococci.
Results. Ten out of 315 women (3.2%) were C. trachomatis-positive. Using traditional methods of microscopy, culture and serology, 42 strains (13.3% of the subjects) obtained from patients were identified as S. agalactiae and further analyzed. The most common serotypes identified were II (18/42, 42.9%), V (11/42, 26.2%) and III (10/42, 23.8%). The less common serotypes found were VII (2/10, 4.8%), and Ib (1/10, 2.4%); no Ia, IV or VII serotypes were found. All the strains were susceptible to penicillin, while 71.4% of them were susceptible to erythromycin and 81.0% were susceptible to clindamycin. Seven isolates (16.7%) were concomitantly resistant to erythromycin and clindamycin.
Conclusion. Chlamydia trachomatis was confirmed in 3.2% of the respondents, and GBS was found in 13.3%, despite a lack of symptoms of infection. The incidence of C. trachomatis infections and GBS colonization in Poland is similar to those in other European countries.
Chlamydia trachomatis, Streptococcus agalactiae, cervical infection
- Persson E, Berg S, Trollfors B, et al. Serotypes and clinical manifestations of invasive Group B streptococcal infections in western Sweden 1998–2001. Clin Microbiol Infect. 2004;10:791–796. doi:10.1111/j.1469-0691.2004.00931.x
- Shabayek S, Spellerberg B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front Microbiol. 2018,9:437. doi:10.3389/fmicb.2018.00437
- Patras KA, Rösler B, Thoman ML, Doran KS. Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus. Mucosal Immunol. 2015;8(6):1339–1348. doi:10.1038/mi.2015.23
- Lyhs U, Kulkas L, Katholm J, et al. Streptococcus agalactiae serotype IV in humans and cattle, Northern Europe. Emerg Infect Dis. 2016;22(12):2097–2103. https://dx.doi.org/10.3201/eid2212.151447
- Farley MM. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis. 2001;33:556–561.
- Wolny K, Gołda-Matuszak E. Streptococcus agalactiae (GBS): The characteristic of isolated strains from productive women’s vagina. Med Dośw Mikrobiol. 2010;62:141–151.
- Kierzkowska M, Majewska A, Kądzielska J, et al. Evaluation of bacterial flora found in the the cervix of pregnant women. Perinatologia, Neonatologia i Ginekologia. 2012;5(1):26–29.
- Meyer T. Diagnostic procedures to detect Chlamydia trachomatis infections. Microorganisms. 2016;4(3):25. doi:10.3390/microorganisms4030025
- European Centre for Disease Prevention and Control. Chlamydia infection. In: ECDC Annual Epidemiological Report for 2017. Stockholm, Sweden: ECDC; 2019
- Storey C, Chopra I. Affinities of β-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities. Antimicrob Agents Chemother. 2001;45(1):303–305. doi:10.1128/AAC.45.1.303-305.2001
- Frej-Mądrzak M, Gryboś A, Gryboś M, et al. PCR diagnostics of Chlamydia trachomatis in asymptomatic infection by women. Ginekol Pol. 2018;89(3):115–119. doi:10.5603/GP.a2018.0020
- Berntsson M, Tunbäck P. Clinical and microscopic signs of cervicitis and urethritis: Correlation with Chlamydia trachomatis infection in female STI patients. Acta Derm Venereol. 2013;93:230–233. doi:10.2340/00015555-1536
- Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016;27(5):333–348. doi:10.1177/0956462415618837
- Frej-Mądrzak M, Teryks-Wołyniec D, Jama-Kmiecik A, Sarowska J, Gościniak G, Choroszy-Król I. Chlamydia trachomatis infections of the genitourinary tract and conjunctiva in adults and children in 2012–2013. Fam Med Primary Care Rev. 2014;16(3):225–227.
- Polish Gynecological Society recommendations regarding Chlamydia trachomatis infections in obstetrics and gynecology. Ginekol Pol. 2007;78:574–575.
- European Centre for Disease Prevention and Control. Guidance on Chlamydia control in Europe – 2015. Stockholm, Sweden: ECDC; 2016. doi:10.2900/667703
- The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, 2019. http://www.eucast.org.
- Sadeh M, Firouzi R, Derakhshandeh A, Khalili MB, Kong F, Kudinha T. Molecular characterization of Streptococcus agalactiae isolates from pregnant and non-pregnant women at Yazd University Hospital, Iran. Jundishapur J Microbiol. 2016;9(2):e30412. doi:10.5812/jjm.30412
- Jannati E, Roshani M, Arzanlou M, Habibzadeh S, Rahimi G, Shapuri R. Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran. Iran J Microbiol. 2012;4(3):130–135.
- Tazi A, Morand PC, Reglier-Poupet H, et al. Invasive group B streptococcal infections in adults, France (2007–2010). Clin Microbiol Infect. 2011;17(10):1587–1589. doi:10.1111/j.1469-0691.2011.03628.x
- Brzychczy-Włoch M, Gosiewski T, Bodaszewska M, Pabian W, Bulanda M, Heczko PB. Analysis of serotypes distribution of Group B streptococci origin from pregnant carriage using multiplex PCR [in Polish]. Med Dośw Mikrobiol. 2009;61(4):293–299.
- Wolny-Koładka K. Evaluation of ITS-PCR and PCR MP techniques for Streptococcus agalactiae genetic differentiation [in Polish]. Med Dośw Mikrobiol. 2014;66(3–4):149–160.
- Garland SM, Cottrill E, Markowski L, et al. Antimicrobial resistance in Group B streptococcus: The Australian experience. J Med Microbiol. 2011;60(Pt 2):230–235. doi:10.1099/jmm.0.022616-0
- Dudareva-Vizule S, Haar K, Sailer A, et al; Chlamydia trachomatis Laboratory Sentinel Team. Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014. Euro Surveill. 2017;22(6):30459.
- Bianchi S, Frati ER, Canuti M, et al. Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18–25 years) in Milan, Italy. J Prev Med Hyg. 2016;57(3):E128–E134.
- Arsić D, Milovanović DR, Ferati AB, et al. Monitoring of Chlamydia trachomatis genitourinary infection in women: Analytical comparative study using public health records from two Balkan countries. Cent Eur J Public Health. 2016;24(1):16–21. doi:10.21101/cejph.a4088
- Friedek D, Ekiel A, Romanik M, et al. Co-occurrence of urogenital mycoplasmas and Group B streptococci with chlamydial cervicitis. Pol J Microbiol. 2005;54(3):253–255.
- Honig E, Mouton JW, van der Meijden WI. The epidemiology of vaginal colonisation with Group B streptococci in a sexually transmitted disease clinic. Eur J Obstet Gynecol Reprod Biol. 2002;105(2):177–180.